Post-operative blood loss after transurethral prostatectomy is dependent on in situ fibrinolysis
- PMID: 9439403
- DOI: 10.1046/j.1464-410x.1997.00483.x
Post-operative blood loss after transurethral prostatectomy is dependent on in situ fibrinolysis
Abstract
Objective: To evaluate whether post-operative blood loss in patients with benign prostatic hyperplasia, undergoing transurethral resection of the prostate (TURP), depends on in situ fibrinolysis in urine, and to determine the relative contributions of the urokinase and tissue-type plasminogen activator systems.
Patients and methods: TURP was performed in 24 men (median age 68.5 years, range 52-78) and the weight of resected tissue, the operative and post-operative blood loss determined. The concentrations of the urokinase- (u-PA) and tissue-type plasminogen activator (t-PA)-related fibrinolysis in their urine was followed using sensitive and specific assays, and the changes related to post-operative blood loss. Measurements of the urinary concentrations of free t-PA activity, t-PA antigen, free u-PA activity, u-PA antigen and fibrin degradation products (FbDP) were determined and the area under the curve for each of these quantities correlated with the post-operative blood loss.
Results: The post-operative blood loss correlated significantly with the per-operative loss (P = 0.047) and the weight of resected tissue (P = 0.029). There was a highly significant correlation between the area under the curve of FbDP in the urine and the post-operative blood loss (P < 0.005), while there was no significant positive correlation between the PA concentration or activity in the urine and post-operative blood loss. There was a significant correlation between the urinary t-PA activity and the amount of FbDP in the urine (P = 0.047), and a significant correlation between the weight of resected tissue and the amount of FbDP in the urine (P = 0.014).
Conclusion: The post-operative blood loss after TURP is significantly related to an increase of the urinary fibrinolytic activity and the enhanced fibrinolytic activity is probably caused by t-PA.
Similar articles
-
Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.Br J Urol. 1997 Jul;80(1):105-10. doi: 10.1046/j.1464-410x.1997.00251.x. Br J Urol. 1997. PMID: 9240188
-
Bleeding and activation of coagulation during and after transurethral prostatectomy: importance of the acute-phase response and prostate specific antigen?BJU Int. 1999 Jun;83(9):990-5. doi: 10.1046/j.1464-410x.1999.00100.x. BJU Int. 1999. PMID: 10368241 Clinical Trial.
-
[Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].Nihon Jinzo Gakkai Shi. 1991 Aug;33(8):719-29. Nihon Jinzo Gakkai Shi. 1991. PMID: 1770632 Japanese.
-
Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.Dan Med Bull. 1993 Sep;40(4):383-408. Dan Med Bull. 1993. PMID: 8222763 Review.
-
The fibrinolytic system in neoplasia.Semin Thromb Hemost. 1996;22(6):459-78. doi: 10.1055/s-2007-999047. Semin Thromb Hemost. 1996. PMID: 9122711 Review.
Cited by
-
Can high-dose tranexamic acid have a role during transurethral resection of the prostate in large prostates? A randomised controlled trial.Arab J Urol. 2021 Jun 3;20(1):24-29. doi: 10.1080/2090598X.2021.1932125. eCollection 2022. Arab J Urol. 2021. PMID: 35223106 Free PMC article.
-
Non-Surgical Bleeding and Transurethral Resection of the Prostate (TURP) Syndrome after TURP Surgery: A Case Report and Literature Review.Pathophysiology. 2024 Jul 12;31(3):367-375. doi: 10.3390/pathophysiology31030027. Pathophysiology. 2024. PMID: 39051224 Free PMC article.
-
Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest. 2012 Feb;141(2 Suppl):e326S-e350S. doi: 10.1378/chest.11-2298. Chest. 2012. PMID: 22315266 Free PMC article.
-
Tranexamic acid is beneficial for reducing perioperative blood loss in transurethral resection of the prostate.Exp Ther Med. 2019 Jan;17(1):943-947. doi: 10.3892/etm.2018.7025. Epub 2018 Nov 28. Exp Ther Med. 2019. PMID: 30651884 Free PMC article.
-
Tranexamic acid for percutaneous nephrolithotomy.Cochrane Database Syst Rev. 2023 Oct 26;10(10):CD015122. doi: 10.1002/14651858.CD015122.pub2. Cochrane Database Syst Rev. 2023. PMID: 37882229 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous